Active Idiotypic Vaccination Versus Control Immunotherapy for Follicular Lymphoma

PURPOSE: Idiotypes (Ids), the unique portions of tumor immunoglobulins, can serve as targets for passive and active immunotherapies for lymphoma. We performed a multicenter, randomized trial comparing a specific vaccine (MyVax), comprising Id chemically coupled to keyhole limpet hemocyanin (KLH) plu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Levy, Ronald, Ganjoo, Kristen N., Leonard, John P., Vose, Julie M., Flinn, Ian W., Ambinder, Richard F., Connors, Joseph M., Berinstein, Neil L., Belch, Andrew R., Bartlett, Nancy L., Nichols, Craig, Emmanouilides, Christos E., Timmerman, John M., Gregory, Stephanie A., Link, Brian K., Inwards, David J., Freedman, Arnold S., Matous, Jeffrey V., Robertson, Michael J., Kunkel, Lori A., Ingolia, Diane E., Gentles, Andrew J., Liu, Chih Long, Tibshirani, Robert, Alizadeh, Ash A., Denney, Dan W.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2014
Schlagworte:
Original Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4039868/
https://ncbi.nlm.nih.gov/pubmed/24799467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.43.9273
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge